Efek Pemberian Metformin dan Metformin+Glimepiride terhadap Kadar HbA1c pada Pasien Diabetes Mellitus Tipe 2

https://doi.org/10.22146/jmpf.72192

Fitri Apriliany(1*), Elis Cholisah(2), Karina Erlianti(3)

(1) Bumigora University
(2) Magister Medical Sciences, University of Cyberjaya, Malaysia.
(3) University of Islam Kalimantan Muhammad Arsyad Al Banjari Banjarmasin
(*) Corresponding Author

Abstract


Diabetes is a chronic metabolic disease and management of DM begins with a helthy lifestyle with early administration of antidiabetic drug. Metformin is the first line therapy in the management of DM. Combination therapy is given if blood sugar level and HbA1c level cannot be controlled with single therapy. This study aimed to determine the effect of giving metformin and metformin+glimepiride on HbA1c levels in DM2 patients. The inclusion criteria were patients DM, received oral antidiabetic at least 6 months, completed medical record, and can speak Indonesia. Exclusion criteria included DM patients receiving insulin therapy, TB patients, patients with mental disorders, and pregnant/breastfeeding women. Sociodemographic data, description of prescribing patterns, and achievement of HbA1c levels were described descriptively. Data analysis using the Wilcoxon test. Respondents in this study were 69 patients,  dominated by women (71%). The types of therapy used were metformin (59.4%) and metformin+glimepiride (40.6%). Achievement of metformin + glimepiride HbA1c levels (67.9%), metformin (48.8%). The difference in decreasing HbA1c levels with metformin (-0.31%±0.38 mg/dL) and metformin+glimepiride -0.33%±0.54 mg/dL (p = 0.000). The results of the analysis showed that there is a significant effect of metformin alone on decreasing HbA1c levels and the addition of glimepiride (metformin + glimepiride) on reducing HbA1c levels in diabetes cannot be controlled with metformin. The implication of this study is as input for comprehensive management guidelines that can be used in an effort to reduce the prevalence of DM. Good management is needed to achieve therapeutic outcomes.

Keywords


Diabetes; Effectiveness; Glimepiride; HbA1C, Metformin



References

  1. Riddle M. et all. American Diabetes Asspciation Standars of Medical Care In Diabetes 2021. J Clin Appl Res Educ. 2021;4(1). doi:https://doi.org/10.2337.dc21-SINT
  2. Williams R et all. IDF Diabetes Atlas Ninth Edition 2019. Vol 6th editio. International Diabetes Federation; 2019.
  3. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a position statement of the american diabetes association and the european association for the study of diabetes. Diabetes Care. 2015;38(1):140-149. doi:10.2337/dc14-2441
  4. Association AD. Standards of Medical Care in Diabetes—2018 Abridged for Primary Care Providers. Clin Diabetes. 2022;40(1):14-37. doi:doi.org/10.2337/cd22-as01
  5. Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: Synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med. 2016;164(8):542-552. doi:10.7326/M15-3016
  6. Wulandari N, Maifitrianti M, Muthi’ah F, Disya NN. Antidiabetic Regimen and Factors Associated with Glycemic Control in Patients with Type 2 Diabetes mellitus in Public Health Centers in Jakarta: A Cross-Sectional Study. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract. 2021;11(3):164. doi:10.22146/jmpf.64431
  7. Hameed M, Khan K, Salman S, Mehmood N. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release. J Ayub Med Coll Abbottabad. 2017;29(2):225-229.
  8. Schlender L, Martinez Y V., Adeniji C, et al. Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: A systematic review for the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr. 2017;17(Suppl 1). doi:10.1186/s12877-017-0574-5
  9. Khairinnisa A, Yusmaini H, Perbandingan Penggunaan Glibenclamid-Metformin dan Glimepirid-Metformin Terhadap Efek Samping Hipoglikemia Pasien Diabetes Melitus Tipe-2 di Kota Tangerang Selatan Bulan Januari - Oktober Tahun 2019 Semin Nasional 2020;(Dm):147-154. https://conference.upnvj.ac.id/index.php/sensorik/article/view/448
  10. Kim H soon, Kim D man, Cha B soo, et al. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea. J Diabetes Investig. 2014;5(6):701-708. doi:10.1111/jdi.12201
  11. Ratnasari PMD, Andayani TM, Endarti D. Analisis Kualitas Hidup Pasien Diabetes Melitus Tipe 2 Berdasarkan Pola Peresepan Antidiabetik dan Komplikasi. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract. 2019;9(4):260. doi:10.22146/jmpf.45862
  12. Ratnasari PMD, Andayani TM, Endarti D. Analisis Outcome Klinis Berdasarkan Kualitas Hidup dan Biaya Medik Langsung Pasien Diabetes Melitus Tipe 2. J Sains Farm Klin. 2020;7(1):15. doi:10.25077/jsfk.7.1.15-22.2020
  13. Dahlan S. Statistik Untuk Kedokteran Dan Kesehatan Seri 1 Edisi 6, , Jakarta. Epidemiologi Indonesia; 2014.
  14. Rodríguez-Almagro J, García-Manzanares Á, Lucendo AJ, Hernández-Martínez A. Health-related quality of life in diabetes mellitus and its social, demographic and clinical determinants: A nationwide cross-sectional survey. J Clin Nurs. 2018;27(21-22):4212-4223. doi:10.1111/jocn.14624
  15. Gillani SW, Ansari IA, Zaghloul HA, et al. Predictors of Health-Related Quality of Life Among Patients with Type II Diabetes Mellitus Who Are Insulin Users: A Multidimensional Model. Curr Ther Res - Clin Exp. 2019;90:53-60. doi:10.1016/j.curtheres.2019.04.001
  16. Tonolo G. Sex-Gender Awareness in Diabetes. Diabetology. 2021;2(2):117-122. doi:10.3390/diabetology2020010
  17. Rachmawati N. Gambaran Kontrol dan Kadar Gula Darah Pada Pasien DM di Poliklinik Penyakit Dalam RSJ Prof.Dr Soerojo Magelang. Skripsi. Published online 2020.
  18. Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69-80. doi:10.1016/S2213-8587(17)30186-9
  19. Soelistijo Soebagijo Adi et all. Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Dewasa Di Indonesia. PB. PERKENI; 2019.
  20. Mansyah B. Sistematik Review: Faktor Resiko Obesitas terhadap Diabetes Mellitus Tipe 2 pada Remaja. J Surya Med. 2021;7(1):233-242. doi:10.33084/jsm.v7i1.2420
  21. Al-Saeed AH, Constantino MI, Molyneaux L, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: The impact of youth-onset type 2 diabetes. Diabetes Care. 2016;39(5):823-829. doi:10.2337/dc15-0991
  22. Shao Y, Liang L, Shi L, Wan C, Yu S. The Effect of Social Support on Glycemic Control in Patients with Type 2 Diabetes Mellitus: The Mediating Roles of Self-Efficacy and Adherence. J Diabetes Res. 2017;2017. doi:10.1155/2017/2804178
  23. Zibaeenezhad MJ, Aghasadeghi K, Bagheri F, et al. The effect of education intervention on glycemic control in patients with type 2 diabetes mellitus. Int Cardiovasc Res J. 2015;9(1):17-21. doi:10.3390/nu10060661
  24. Pesaud H, Williams S. Occupational Stress and Increased Risk for Type 2-Diabetes: A Narrative Review. J Complement Med Altern Healthc. 2017;2(5). doi:10.19080/jcmah.2017.02.555599
  25. Sliwinska-Mosson M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diabetes Vasc Dis Res. 2017;14(4):265-276. doi:10.1177/1479164117701876
  26. Orlando V, Guerriero F, Putignano D, et al. Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy. Curr Diabetes Rev. 2015;12(2):100-106. doi:10.2174/1573399811666150701120408
  27. Mohan V, Zargar A, Chawla M, et al. Efficacy of a combination of metformin and vildagliptin in comparison to metformin alone in type 2 diabetes mellitus: A multicentre, retrospective, real-world evidence study. Diabetes, Metab Syndr Obes Targets Ther. 2021;14(August):2925-2933. doi:10.2147/DMSO.S315227
  28. Hirst JA, Farmer AJ, Dyar A, Lung TWC, Stevens RJ. Estimating the effect of sulfonylurea on HbA1c in diabetes: A systematic review and meta-analysis. Diabetologia. 2013;56(5):973-984. doi:10.1007/s00125-013-2856-6
  29. Tao T, Wu P, Wang Y, Liu W. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment. BMC Endocr Disord. 2018;18(1):1-13. doi:10.1186/s12902-018-0243-5



DOI: https://doi.org/10.22146/jmpf.72192

Article Metrics

Abstract views : 755

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats